Centralised cancer services key to better UK outcomes
This article was originally published in Clinica
New evidence published in the British Journal of Cancer on the importance of providing specialist breast cancer care is being billed as the first concrete data to support the development of centralised oncology units. It comes in the wake of renewed criticism of the UK's cancer care outcomes and delays in increasing access to technology.
You may also be interested in...
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.